SwishX has launched a groundbreaking AI platform tailored for the pharmaceutical and MedTech sectors, raising $2.2 million in seed funding to support its mission of transforming commercial operations.
The Bengaluru-based startup's new Agentic AI platform aims to address operational inefficiencies prevalent in the pharmaceutical and medical device industries. Traditional methods often rely on outdated practices, such as spreadsheets and manual workflows, which can hinder timely decision-making and reporting. With its innovative platform, SwishX seeks to enhance revenue outcomes by providing real-time insights into various business operations, including sales, contracts, and tenders.
SwishX has set ambitious goals, targeting $5 million in annual recurring revenue and over 100 enterprise customers by FY2026-27. Additionally, the company plans to expand its reach into several global markets, including Latin America and Southeast Asia.
According to CEO Dushyant Sapre, the transformation within the industry is shifting from laboratory advancements to market execution strategies. The introduction of AI agents is expected to revolutionize how companies operate, offering unprecedented visibility and autonomy in their commercial endeavors.